Literature DB >> 914

Overview: maintenance therapy in psychiatry: I. Schizophrenia.

J M Davis.   

Abstract

Hospital psychiatry has evolved from long-term "treatment" programs that were primarily custodial to the successful pharmacological treatment of acute psychotic episodes. Unfortunately, many patients still return to the hospital with relapses. This so-called revolving door syndrome draws attention to the critical importance of preventing as well as treating acute episodes. In the first part of this overview, the author reviews the clinical literature on prophylactic treatment of schizophrenia with maintenance antipsychotic drugs. The second part will review the literature on prophylactic treatment of affective disorders with lithium and tricyclics. In the opinion of the author these drugs provide the potential for truly preventive psychiatry.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 914     DOI: 10.1176/ajp.132.12.1237

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  33 in total

Review 1.  Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.

Authors:  E Stip
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

2.  A comparative trial of the decanoates of flupenthixol and fluphenazine.

Authors:  M Hamilton; I R Card; G G Wallis; M R Mahmoud
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

3.  The stages of schizophrenia and their management.

Authors:  B F Hoffman
Journal:  Can Fam Physician       Date:  1982-11       Impact factor: 3.275

4.  Does short term placebo treatment of chronic schizophrenia produce long term harm?

Authors:  D A Curson; S R Hirsch; S D Platt; R W Bamber; T R Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-20

Review 5.  Cochrane Schizophrenia Group.

Authors:  Clive E Adams; Evandro S F Coutinho; John Davis; Lorna Duggan; Stefan Leucht; Chunbo Li; Prathap Tharyan
Journal:  Schizophr Bull       Date:  2008-01-31       Impact factor: 9.306

Review 6.  Psychosocial treatments to promote functional recovery in schizophrenia.

Authors:  Robert S Kern; Shirley M Glynn; William P Horan; Stephen R Marder
Journal:  Schizophr Bull       Date:  2009-01-27       Impact factor: 9.306

7.  Prophylactic effect of neuroleptics in symptom-free schizophrenics.

Authors:  T Nishikawa; A Tsuda; M Tanaka; I Koga; Y Uchida
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Outcome and risks of ultra-long-term treatment with an oral neuroleptic drug. Relationship between perazine serum levels and clinical variables in schizophrenic outpatients.

Authors:  A Pietzcker; A Poppenberg; J Schley; B Müller-Oerlinghausen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981

Review 9.  Drug treatment of resistant schizophrenia. Limitations and recommendations.

Authors:  A E Farmer; A Blewett
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

10.  Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal.

Authors:  B Ekblom; K Eriksson; L H Lindström
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.